We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WING icon
376
CALL
Wingstop
WING
$3.68B
$29.2M 0.04%
+69,000
New +$26.5M
NGG icon
377
National Grid
NGG
$82.7B
$29.1M 0.04%
+543,606
New +$32.8M
AVGO icon
378
CALL
Broadcom
AVGO
$1.82T
$28.9M 0.04%
180,000
+151,000
+521% +$21.2M
XBI icon
379
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$28.8M 0.04%
311,000
+165,300
+113% +$14.8M
MRVI icon
380
Maravai LifeSciences
MRVI
$997M
$28.7M 0.04%
4,004,884
-824,862
-17% -$7.12M
CELH icon
381
PUT
Celsius Holdings
CELH
$6.93B
$28.5M 0.04%
+500,000
New +$37.8M
FLYW icon
382
Flywire
FLYW
$1.96B
$28.4M 0.04%
1,735,505
+110,893
+7% +$2.09M
S icon
383
SentinelOne
S
$6.22B
$28.4M 0.04%
1,349,187
+797,449
+145% +$16.4M
ANSS
384
DELISTED
Ansys
ANSS
$28.1M 0.04%
87,524
-61,371
-41% -$20.1M
TTWO icon
385
Take-Two Interactive
TTWO
$43B
$28.1M 0.04%
180,732
+46,920
+35% +$7.12M
PRIM icon
386
Primoris Services
PRIM
$4.69B
$28.1M 0.04%
+563,025
New +$27.9M
BEKE icon
387
KE Holdings
BEKE
$16.8B
$28.1M 0.04%
1,982,660
-586,833
-23% -$9.19M
GAP
388
The Gap Inc
GAP
$6.84B
$27.9M 0.04%
1,169,440
-1,392,104
-54% -$32.4M
EVRG icon
389
Evergy
EVRG
$20.1B
$27.9M 0.04%
+526,995
New +$28M
PCRX icon
390
Pacira BioSciences
PCRX
$1.02B
$27.8M 0.04%
971,143
+159,791
+20% +$4.55M
SNOW icon
391
CALL
Snowflake
SNOW
$92.9B
$27.7M 0.04%
205,400
+175,900
+596% +$26M
HUN icon
392
Huntsman Corp
HUN
$2.24B
$27.6M 0.04%
1,213,629
+376,423
+45% +$9.17M
WEX icon
393
WEX
WEX
$6.11B
$27.5M 0.04%
155,319
+28,739
+23% +$5.86M
USFD icon
394
US Foods
USFD
$21.4B
$27.5M 0.04%
+518,552
New +$27.3M
OPCH icon
395
Option Care Health
OPCH
$3.4B
$27.4M 0.04%
990,104
-2,244,016
-69% -$66.9M
TW icon
396
Tradeweb Markets
TW
$21.3B
$27.4M 0.04%
258,699
-583,251
-69% -$61.6M
MS icon
397
PUT
Morgan Stanley
MS
$337B
$27.2M 0.04%
280,000
-1,342,800
-83% -$128M
ACN icon
398
Accenture
ACN
$89.9B
$27M 0.04%
+88,977
New +$27.3M
AZO icon
399
AutoZone
AZO
$48.3B
$27M 0.04%
9,100
-4,845
-35% -$14.2M
AEO icon
400
American Eagle Outfitters
AEO
$2.85B
$26.8M 0.04%
1,343,917
-742,703
-36% -$17M

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.